Page last updated: 2024-12-11

24,24-difluoro-1,25-dihydroxyvitamin d3

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

24,24-difluoro-1,25-dihydroxyvitamin D3: RN given refers to (1alpha,3beta,5Z,7E)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6438701
SCHEMBL ID10890206
MeSH IDM0080571

Synonyms (8)

Synonym
ccris 5802
(1s,3r,5z)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-5,5-difluoro-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
24,24-difluoro-1alpha,25-dihydroxyvitamin d3
72696-49-2
24,24-difluoro-1,25-dihydroxyvitamin d3
24,24-difluorocalcitriol
SCHEMBL10890206
pqkfudvfsoehdq-kbbgflfpsa-n

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Due to the wider therapeutic dosage range, this compound might be of clinical value."( Biological activity of fluorine-substituted 1,25-dihydroxyvitamin D3 in rats, in chicken and in Japanese quails.
Rambeck, WA; Weiser, H; Zucker, H, 1986
)
0.27
" Renal function was most severely affected in cows treated with 24,24-F2-dihydroxycholecalciferol and was evident even at the 100-micrograms dosage level."( Bone resorption, renal function and mineral status in cows treated with 1,25-dihydroxycholecalciferol and its 24-fluoro analogues.
Boris, A; Goff, JP; Horst, RL; Littledike, ET; Uskokovic, MR, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (80.00)18.7374
1990's2 (13.33)18.2507
2000's0 (0.00)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.36 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]